NCT00283777View on ClinicalTrials.gov

Chromium and Insulin Action

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 1998

Primary Completion Date

January 31, 2003

Study Completion Date

April 30, 2003

Conditions
Type 2 Diabetes
Interventions
DRUG

Chromium Picolinate

Trial Locations (1)

05410

University of Vermont, Burlington

All Listed Sponsors
lead

Pennington Biomedical Research Center

OTHER

NCT00283777 - Chromium and Insulin Action | Biotech Hunter | Biotech Hunter